Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT-EHA CAR-T 2019 | The future landscape of CAR T-cell therapy

Elaine Vickers • 20 Mar 2019
EBMT-EHA CAR-T 2019
Acute Lymphoblastic Leukemia General Leukemia Lymphoma CAR-T

In this video, Elaine Vickers, PhD, of Science Communicated Ltd., Manchester, UK, discusses the future of immunotherapy with CAR T-cells. Speaking at the 1st European CAR T-Cell Meeting, held in Paris, France, Dr Vickers mentions the most anticipated upcoming strategies that may improve the performance of CAR T-cell therapy in treating cancer. This meeting was co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

More from Elaine Vickers

0:59
The importance of nursing education in CAR-T therapy
Elaine Vickers • 10 Feb 2023
1:33
Exciting updates in the CAR-T space from an educator's perspective
Elaine Vickers • 10 Feb 2023
1:16
CAR-T Meeting 2020 highlights: CAR T-cell design, molecular biology & solid tumors
Elaine Vickers • 30 Jan 2020
2:21
Importance of educating nurses on CAR T-cell therapy
Elaine Vickers • 30 Jan 2020

Related Videos

3:12
Addressing cardiotoxicity following CAR-T therapy and improving clinical practice
Arjun Ghosh • 25 Apr 2024
1:51
Should MRD eradication be the goal when treating every patient with CLL?
Dima El-Sharkawi • 28 Apr 2024
4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals